Bing Peng
Sichuan University
53 Papers
228 Citations
Bing Peng is an academic researcher from Sichuan University. The author has contributed to research in topics: Medicine & Splenectomy. The author has an hindex of 13, co-authored 36 publications.
Chat about Author
Papers
Comparative treatment and literature review for laparoscopic splenectomy alone versus preoperative splenic artery embolization splenectomy
TL;DR: Splenic artery embolization is a useful intraoperative adjunctive procedure for patients with splenomegaly because of the benefit of perioperative outcomes and reduced the operating time and decreased intraoperative blood loss when compared with laparoscopic splenectomy alone or opensplenectomy.
58
Laparoscopic splenectomy is an effective and safe intervention for hypersplenism secondary to liver cirrhosis.
TL;DR: Compared with group 3, patients in group 1 were older, had lower preoperative hemoglobin levels and leukocyte counts, poorer Child-Pugh class, required more operation time, and suffered more estimated blood loss; however, there were no statistically significant differences in terms of conversion rates, transfusion rates, complication rates, and postoperative course.
54
Laparoscopic partial splenectomy is safe and effective in patients with focal benign splenic lesion
TL;DR: Laparoscopic partial splenectomy is safe and effective in patients with focal benign splenic lesion and potentially retains some splenic function, and confers the benefit of a minimal access technique.
41
Long-term postoperative outcomes of hypersplenism: laparoscopic versus open splenectomy secondary to liver cirrhosis
TL;DR: LS can be considered a well-disposed surgical procedure with good surgical outcomes compared with OS, and all the patients showed complete or partial hematologic response to splenectomy and exhibited improvement in liver function.
33
Laparoscopic splenectomy for immune thrombocytopenia (ITP) patients with platelet counts lower than 1 × 109/L
TL;DR: Laparoscopic splenectomy is a feasible technique in the treatment of ITP patients, characterized by severe mucocutaneous bleeding, extremely low platelet count, and normal prothrombin time (PT) and activated partial thromboplastin time (APTT).
29